Project Grant UC153080
- This Cooperative Agreement award, funded by the Centers for Disease Control and Prevention (CDC) under the "Organized Approaches to Increase Colorectal Cancer Screening" program (CFDA 93.800), aims to increase colorectal cancer screening rates among underserved populations in Maine. The $425,000 award to the Maine Department of Health and Human Services (Maine DHHS) will support the implementation of evidence-based interventions (EBIs) in partnership with Federally Qualified Health...
- This Project Grant award, funded by the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program, supports a comprehensive $398,972 study on improving healthcare quality and equity for newborns with prenatal substance exposure. The study, conducted by the University of California, Davis in collaboration with the Better Outcomes through Research for Newborns (BORN) network and the EMPOWER stakeholder group, aims to:...
- This federal Cooperative Agreement award, funded by the National Center for Chronic Disease Prevention and Health Promotion under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800), will provide $684,000.00 to Health Research, Inc., a not-for-profit organization in New York, to increase colorectal cancer (CRC) screening rates across the state. The project will partner with primary care clinics, including Federally Qualified Health Centers and Rural Health...
- The Massachusetts Department of Public Health (MDPH) received a $539,641 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Organized Approaches to Increase Colorectal Cancer Screening (CFDA 93.800) program. The purpose of this 5-year award (8/30/2025 - 8/29/2030) is to partner with community health centers and federally qualified health centers (FQHCs) in Massachusetts to implement evidence-based interventions aimed at increasing colorectal cancer...
- This federal Cooperative Agreement award of $682,625 from the National Center for Chronic Disease Prevention and Health Promotion (CFDA 93.800 - Organized Approaches to Increase Colorectal Cancer Screening) aims to increase colorectal cancer (CRC) screening rates among underserved populations aged 45-75 in rural New Hampshire. The awardee, Mary Hitchcock Memorial Hospital (doing business as Dartmouth-Hitchcock), will develop partnerships with clinics serving populations with low screening...
- The Hawaii Department of Health (HDOH) was awarded a $761,137 Maternal and Child Health Services Block Grant (CFDA 93.994) from the U.S. Department of Health and Human Services Health Resources and Services Administration (HRSA). The grant, awarded on October 1, 2025, will fund the HDOH Children With Special Health Needs - Newborn Screening (NBS) Division to provide comprehensive public health services and critical medical screening capabilities over a 2-year project period ending September...
- The Centers for Disease Control and Prevention (CDC) has awarded a $827,916 Cooperative Agreement to the Connecticut Department of Public Health (DPH) under the "Organized Approaches to Increase Colorectal Cancer Screening" (CFDA 93.800) program. This 5-year award, with a performance period from August 30, 2025 to August 29, 2030, will support efforts to increase colorectal cancer screening, diagnostic services, and treatment referrals by implementing evidence-based interventions at...
- This federal Project Grant award of $120,000.00, provided by the Maternal and Child Health Bureau (CFDA 93.877 Autism Collaboration, Accountability, Research, Education, and Support Program), supports research to enhance the effectiveness of the medical home model for children with Autism Spectrum Disorder (ASD). The key objectives are to: (1) evaluate the psychometric properties of the National Survey of Children's Health (NSCH) medical home measure, (2) determine relationships between...
- This $385,877 federal Project Grant award from the U.S. Department of Health and Human Services Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program aims to optimize the integration of child psychosocial screenings in primary care. The grant will fund the development and testing of the CareLoop intervention, which uses process service mapping to enhance referral and linkage pathways and promote whole-person,...
- The Centers for Disease Control and Prevention (CDC) awarded a $684,000 Cooperative Agreement to the Alaska Native Tribal Health Consortium (ANTHC) under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800). The goal of this 5-year award, running from August 30, 2025 to August 29, 2030, is to expand the use of evidence-based interventions to improve colorectal cancer screening rates among the 89,090 people served by 7 Alaska regional tribal healthcare systems...
COOPERATIVE NEWBORN SCREENING SYSTEM PRIORITIES PROGRAM - THE MAINE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTER FOR DISEASE CONTROL AND PREVENTION'S (MAINE CDC) NEWBORN BLOODSPOT SCREENING (NBS) PROGRAM IS PROPOSING THIS PROJECT TO STRENGTHEN THE NEWBORN HEALTH AND SCREENING SYSTEM TO PROVIDE SERVICES TO NEWBORNS AND CHILDREN WITH, OR AT RISK FOR, HERITABLE DISORDERS AND HELP THEM ACHIEVE THE BEST POSSIBLE OUTCOMES. MAINE CDC NBS MAINTAINS CONSISTENTLY HIGH SCREENING RATES AND TIMELINESS IN THE OVERALL NBS SYSTEM, INCLUDING HOW LONG IT TAKES THE SPECIMENS TO GET FROM THE HOSPITALS TO THE LABORATORY. THE GOAL OF THIS PROJECT IS TO ENSURE THE PROGRAM IS SUCCESSFULLY SERVING ALL FAMILIES IN MAINE BY ADDRESSING HEALTH EQUITY AND DEVELOPING A MORE COHESIVE, EFFICIENT, AND SUSTAINABLE INFORMATION SYSTEM TO SUPPORT POPULATION NEWBORN HEALTH. SPECIFICALLY, THE NBS PROGRAM PLANS TO 1) CONDUCT QUALITY IMPROVEMENT (QI) ACTIVITIES AROUND THE COLLECTION OF BLOODSPOT SPECIMENS, TESTING OF SPECIMENS, REPORTING OF RESULTS, AND IMPLEMENTING SCREENING FOR NEWLY ADDED RECOMMENDED UNIFORM SCREENING PANEL (RUSP) CONDITIONS AND 2) IMPLEMENT NEW APPROACHES TO SHORT-TERM AND LONG-TERM FOLLOW-UP BY EXPANDING ACCESS TO DIAGNOSIS AND TREATMENT RESOURCES FOR PROVIDERS AND FAMILIES WITH A SPECIAL FOCUS ON REACHING RURAL AND UNDERSERVED POPULATIONS AND EMPOWERING FAMILIES TO ACTIVELY ENGAGE IN ALL ASPECTS OF THE NBS SYSTEM. THE NBS CO-PROPEL FUNDING WILL ALLOW THE MAINE CDC NBS PROGRAM TO ACHIEVE THE PROPOSED GOALS BY DEVELOPING AN INFORMATION SYSTEM WITH INTEROPERABILITY BETWEEN HOSPITALS, BIRTHING CENTERS, MIDWIVES, PEDIATRICIANS, AND SPECIALTY PEDIATRIC PROVIDERS. THIS IS VITAL TO IMPROVING SHORT AND LONG-TERM FOLLOW-UP SERVICES. MAINE NBS WILL ENGAGE IN TECHNICAL ASSISTANCE FROM EXPERTS IN INTEROPERABILITY TO PERFORM A READINESS ASSESSMENT AND DEVELOP A ROADMAP AS WELL AS EMPLOY A FULL-TIME CONTRACTED HEALTH INFORMATICS SPECIALIST TO IMPLEMENT THE SYSTEM. THE FUNDING WILL ALSO SUPPORT THE DEVELOPMENT AND IMPLEMENTATION OF A COMMUNITY-BASED SYSTEM OF CARE THROUGH PARTNERSHIPS WITH FAMILIES, THOSE WITH LIVED EXPERIENCE, HEALTH CARE AND OTHER SERVICE PROVIDERS, AND OTHER STAKEHOLDERS. THE MAINE NBS PROGRAM EXAMINED RACE, ETHNICITY, AND TYPE OF INSURANCE FOR THE 31 BABIES BORN IN 2022, WHO WERE DIAGNOSED WITH A CONDITION: 22.5% INDICATED A RACE OTHER THAN WHITE, 3% IDENTIFIED AS HISPANIC, AND 55% WERE ON PUBLIC INSURANCE (MAINECARE) AT TIME OF BIRTH. THE NBS PROGRAM DOES NOT HAVE INFORMATION ON WHETHER BABIES WHO ARE PART OF MAINE'S UNDERSERVED POPULATIONS EXPERIENCE DIFFERENCE IN TIMELINESS OF SHORT- OR LONG-TERM FOLLOW-UP. THIS FUNDING WILL ALLOW MAINE TO EXPLORE THIS, AND IF DIFFERENCES ARE IDENTIFIED TO MAKE CHANGES TO ENSURE THAT ALL BABIES, REGARDLESS OF THESE FACTORS, MOVE THROUGH THE NBS SYSTEM AND RECEIVE THE NECESSARY FOLLOW-UP CARE WITHIN THE RECOMMENDED TIMEFRAMES.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $11.8k | 8/21/25 | ||
| Not listed | $345.0k | 6/30/25 | ||
| Not listed | $345.0k | 6/30/25 | ||
| Not listed | $0 | 6/3/25 | ||
| Not listed | $0 | 6/3/25 |